Ketogenic Diet in Pediatric Brain Tumor

Open-label, single-arm trial, sponsored by Washington University School of Medicine. Primary endpoints: Feasibility of combining a ketogenic diet with chemotherapy in children with relapsed brain tumors as measured by the number of patients who can recruited with 3 years and Feasibility of combining a ketogenic diet with chemotherapy in children with relapsed brain tumors as measured by if at least 80% of the patients comply with the intervention at 2 years. Started May 2019; status: terminated.